Expert Answer
What does a GLP-1 do besides weight loss?
Quick Answer
Beyond weight, GLP-1s show cardiovascular event reduction that appears partly independent of weight loss (via anti-inflammatory effects), plus emerging signals in addiction — curbing alcohol and compulsive cravings (Attia; Knight via Huberman). The "does it slow aging itself" claim is unproven outside obesity/diabetes, and high doses carry real risks (depression, rare eye issues).
Moderate Consensus
on GLP-1 Agonists overall
What Researchers Say
Covers cardiovascular benefit and off-label use for alcohol/addiction cravings, while stressing that a true geroprotective (anti-aging) effect remains unproven outside obesity/diabetes.
Features Dr. Zachary Knight on cardiac benefits that appear independent of weight loss, possibly via suppression of systemic inflammation (the "inflammatory reflex").
Features Dr. Ben Bikman, who acknowledges benefits but flags higher-dose risks including increased depression and rare blindness (NAION).
Argues GLP-1s should not be taken for longevity — the risks and dependency outweigh benefits when root-cause metabolic health is achievable through lifestyle.
Detailed Answer
The weight loss is only part of the story, and the "what else" is where the science gets genuinely interesting — and where the panel splits.
Cardiovascular: Dr. Zachary Knight (via Huberman) explains that the cardiac benefits of GLP-1s appear partly independent of weight loss, possibly by acting on the "inflammatory reflex" to suppress systemic inflammation. Preventive cardiologist Dr. Aaron Mikos (via Attia) adds that they reduce cardiovascular events through blood-pressure, lipid, and anti-atherosclerotic effects, not just blood-sugar lowering.
Addiction: this is one of the better-grounded off-label signals. Attia describes "striking success in silencing cravings" in treatment-refractory alcohol use disorder; addiction psychiatrist Dr. Anna Lembke (via Attia) and Dr. Keith Humphreys (via Huberman) both frame GLP-1s as a promising new frontier for alcohol and compulsive behaviors — a potential "two-for" alongside obesity. Brain-health researchers (Dr. Lisa Mosconi via Attia; Dr. Eric Topol via Hyman) note emerging, early interest in neuroprotection and Alzheimer's, driven by the anti-inflammatory effects.
The honest limits: Attia is careful that a true geroprotective ("slows aging itself") effect is unproven — the data is confined to people with obesity or diabetes, making it hard to isolate. And Dr. Ben Bikman (via Patrick) supplies the counterweight: at higher doses he flags increased depression risk and rare blindness (NAION), calling the drugs a "temporary tool, not a lifetime solution." Hyman goes further, arguing flatly that GLP-1s should not be taken for longevity. So: real and expanding benefits beyond weight, with genuine risks and an unproven anti-aging headline.
Related Questions
Do GLP-1s help the heart?
Yes — they reduce cardiovascular events partly independent of weight loss, likely via anti-inflammatory and blood-pressure/lipid effects (Knight via Huberman; Mikos via Attia).
Can GLP-1s help with alcohol or addiction?
Emerging evidence says yes. Attia reports success curbing alcohol cravings; Lembke and Humphreys call it a promising frontier for compulsive behaviors. Trials are still needed.
Do GLP-1s slow aging?
Unproven. Attia stresses the data is confined to obesity/diabetes, so a true geroprotective effect can't yet be isolated. High doses also carry depression and rare eye-risk signals.
More Questions About GLP-1 Agonists
Get the exact protocol for GLP-1 Agonists
This page covers what researchers agree on. Pro gives you the specific dosages, timing schedules, and interaction warnings they each recommend — with video citations you can verify.
- Expert-by-expert breakdowns on any topic
- Chat with 1000+ hours of research data
- Video citations with timestamps you can check
Cancel anytime
Full GLP-1 Agonists Consensus Report
See what all the experts agree and disagree on